Bifurcation Lesions Market is Expected to Clock a Notable A CAGR of 4% and Reach USD 888.2 Million by 2032
Market Summary: The global market for bifurcation lesions reached a size of USD 624 million in 2022 and is expected to reach USD 888.2 million by 2032, with a projected revenue compound annual growth rate (CAGR) of 4% during the forecast period. The growth is primarily driven by factors such as the increasing prevalence of cardiovascular diseases, a growing demand for minimally invasive procedures, and advancements in medical equipment technology.
Cardiovascular illnesses, particularly Coronary Artery
Disease (CAD), remain a leading global cause of death. In 2019, CAD was
responsible for 17.9 million deaths, accounting for 32% of all global
fatalities according to the World Health Organization (WHO).
Bifurcation lesions occur when an artery divides into two
smaller channels, potentially obstructing blood flow and oxygen supply to the
heart. The rising incidence of CAD and bifurcation lesions has led to a demand
for more efficient treatment options. Minimally invasive techniques are
preferred for treating bifurcation lesions due to their lower risk of
complications, shorter hospital stays, and quicker recovery. Common treatment
methods for bifurcation lesions include Percutaneous Coronary Intervention (PCI)
and Drug-Eluting Stents (DES). Furthermore, advancements in medical equipment
technology, such as specialized stents designed for bifurcation cases, are
expected to drive market growth.
Get a sample copy of the Bifurcation
Lesions Market report: https://www.reportsanddata.com/download-free-sample/7203
Key Insights: Type Outlook:
- True
bifurcation lesions occur when an artery divides into two branches,
requiring treatment for both. Specialized equipment like customized
bifurcation stents and balloons are often used for such cases. The demand
for genuine bifurcation lesion therapy is expected to rise due to an
increase in PCI procedures and CAD prevalence.
- Non-true
bifurcation lesions involve treating only one branch of a blood vessel,
making them less complex. The non-true bifurcation lesions market is
expected to grow steadily due to the expanding use of PCI treatments.
- Technological
advancements and imaging technologies like Intravascular Ultrasound (IVUS)
and Optical Coherence Tomography (OCT) are likely to further boost the
true bifurcation lesions segment's growth.
Treatment Outlook:
- Drug-eluting
stents (DES) are specialized stents coated with medications to prevent
restenosis. They are considered the gold standard for bifurcation lesion
treatment due to their effectiveness in preventing restenosis and coverage
of both bifurcation branches.
- Bare-metal
stents (BMS) are uncoated stents used to keep blood vessels open. While
BMS are effective in reducing short-term problems, DES are preferred due
to their lower restenosis risk.
- Balloon
angioplasty is a minimally invasive procedure for non-complex bifurcation
lesions and is expected to grow at a faster rate than overall treatment
methods.
- Coronary
artery bypass grafting (CABG) is a surgical option for complex bifurcation
lesions, often recommended for patients ineligible for PCI.
- The
"Others" segment includes alternative therapies such as rotating
atherectomy, cutting balloon angioplasty, and laser angioplasty, which may
be used for difficult bifurcation lesions.
Regional Outlook:
- The
North American market for bifurcation lesions is the largest due to the
high prevalence of cardiovascular diseases (CVDs) and a strong healthcare
infrastructure. Awareness campaigns also contribute to market expansion.
- Europe
is the second-largest regional market, driven by advanced medical
technology, aging populations, and increased CVD awareness.
- Asia
Pacific is expected to experience the fastest growth, primarily due to the
rising incidence of CVDs, increased disposable income, and healthcare
infrastructure improvements. China and India are significant contributors
to this growth.
- South
America, the Middle East, and Africa are also expected to see significant
growth, thanks to advanced medical technologies and the adoption of
minimally invasive surgeries, along with increasing disease awareness.
Competitive Landscape:
- Major
players in the bifurcation lesions market include Abbott Laboratories,
Boston Scientific Corporation, Johnson & Johnson Services, Inc.,
Medtronic plc, Terumo Corporation, Cook Medical LLC, BIOTRONIK SE &
Co. KG, C. R. Bard, Inc., and Endologix, Inc.
Strategic Developments:
- Several
key players have announced innovative products for treating bifurcation
lesions, including Medtronic's Sola Vascular Self-Expanding Stent System,
Abbott Laboratories' acquisition of Walk Vascular, Boston Scientific
Corporation's Ranger Drug-Coated Balloon, and Terumo Corporation's
Ultimaster™ Tansei™ Drug-Eluting Stent System.
New Product Launches:
- Companies
like Abbott Laboratories, Boston Scientific Corporation, Medtronic plc,
and Cook Medical LLC have introduced new products to enhance the treatment
of bifurcation lesions.
Segments Covered in the Report:
- The
report segments the bifurcation lesions market by type, treatment, and
region. It provides historical data and forecasts revenue growth at
global, regional, and country levels.
Report Scope:
- The
report covers data from 2022 with a 4% CAGR, projecting a revenue of USD
888.2 million in 2032.
- Historical
data from 2020-2021 and forecasts from 2022-2032.
- Quantitative
units in USD Million.
- The
report includes market trends, segments, and sub-segments, offering
insights into the global bifurcation lesions market.
Explore Trending Reports:
Monoethylene
Glycol Market-https://www.globenewswire.com/news-release/2019/08/27/1907300/0/en/Monoethylene-Glycol-Market-To-Reach-USD-36-98-Billion-By-2026-Reports-And-Data.html
Heat
Stabilizers Market-https://www.globenewswire.com/news-release/2019/10/07/1925992/0/en/Heat-Stabilizers-Market-To-Reach-USD-5-34-Billion-By-2026-Reports-And-Data.html
Low-VOC
Coating Additive Market-https://www.globenewswire.com/news-release/2020/05/06/2028445/0/en/Low-VOC-Coating-Additive-Market-To-Reach-USD-8-70-Billion-By-2027-Reports-and-Data.html
Request a customization of the report: https://www.reportsanddata.com/request-customization-form/7203
Thank
you for reading our report. To know more about the customization or any query
about the report contents, please connect with us and our team will ensure the
report is tailored to meet your requirements.
About Reports and Data
Reports
and Data is a market research and consulting company that provides syndicated
research reports, customized research reports, and consulting services. Our
solutions purely focus on your purpose to locate, target, and analyse consumer
behaviour shifts across demographics, across industries, and help clients to
make smarter business decisions. We offer market intelligence studies ensuring
relevant and fact-based research across multiple industries, including
Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently
update our research offerings to ensure our clients are aware of the latest
trends existent in the market. Reports and Data has a strong base of
experienced analysts from varied areas of expertise. Our industry experience
and ability to develop a concrete solution to any research problems provides
our clients with the ability to secure an edge over their respective
competitors.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
Browse Latest Blogs: https://www.reportsanddata.com/blogs
Comments
Post a Comment